Cargando…

Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial

BACKGROUND: While combined oral contraceptives (COCs) are commonly used to treat polycystic ovary syndrome (PCOS), comparative data regarding metabolic effects of different progestogens on this patient population are missing. This study aimed to compare the different effects of drospirenone (DRP)-co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qiu-Yi, Song, Yong, Huang, Wei, Xiao, Li, Wang, Qiu-Shi, Feng, Gui-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831520/ https://www.ncbi.nlm.nih.gov/pubmed/27064030 http://dx.doi.org/10.4103/0366-6999.179783

Ejemplares similares

Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial
por: Behboudi-Gandevani, Samira, et al.
Publicado: (2019)

Women consuming oral contraceptives containing cyproterone acetate and ethinylestradiol show a higher risk of thyroid cancer than nonusers
por: Lai, Pei-Hsuan, et al.
Publicado: (2023)

Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
por: Mathur, Ruchi, et al.
Publicado: (2008)

Ethinylestradiol(30μg)-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?
por: Ilie, Ioana Rada, et al.
Publicado: (2012)

Drospirenone-containing oral contraceptives and venous thromboembolism: an analysis of the FAERS database
por: Madigan, David, et al.
Publicado: (2018)

Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
por: Podfigurna, A., et al.
Publicado: (2019)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Voltammetric Determination of Cyproterone Acetate in Pharmaceutical Preparations
por: El-Enany, Nahed, et al.
Publicado: (2010)

Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial
por: Jaisamrarn, Unnop, et al.
Publicado: (2018)

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
por: Morimont, Laure, et al.
Publicado: (2022)

Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program
por: AlHussain, Fatimah, et al.
Publicado: (2020)

The benefits of estetrol addition to drospirenone for contraception
por: Foidart, Jean Michel, et al.
Publicado: (2023)

Correction: Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis
por: Kim, Chan Hee, et al.
Publicado: (2020)

Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor
por: Chen, Chih-Shou, et al.
Publicado: (2021)

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2017)

Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen
por: Mansour, Diana, et al.
Publicado: (2011)

A Comparative Efficacy of Low-Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms
por: Wichianpitaya, Jirath, et al.
Publicado: (2013)

Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women
por: Kim, Nayoung, et al.
Publicado: (2015)

Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
por: Mehrabian, Ferdous, et al.
Publicado: (2016)

PMON208 METFORMIN, SPIRONOLACTONE AND ORAL CONTRACEPTIVES IN POLYCYSTIC OVARY SYNDROME: A NETWORK META-ANALYSIS
por: Rodriguez-Gutierrez, Rene, et al.
Publicado: (2022)

Preparation and Evaluation of Intravaginal Ring Containing Drospirenone
por: Zhang, Ying, et al.
Publicado: (2013)

Vitamin D serum levels in women using contraception containing drospirenone – a preliminary study
por: Ciebiera, Michał, et al.
Publicado: (2017)

A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma.
por: Keating, J. J., et al.
Publicado: (1989)

Unilateral proptosis and blindness caused by meningioma in a patient treated with cyproterone acetate
por: Sys, Celine, et al.
Publicado: (2015)

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
por: Montani, David, et al.
Publicado: (2014)

SAT397 A Low Dose Cyproterone Acetate In Feminizing Hormone Treatment
por: Korpaisarn, Sira, et al.
Publicado: (2023)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne
por: Tan, Jerry KL, et al.
Publicado: (2010)

An Oral Contraceptive Containing Estetrol 15 MG and Drospirenone 3 MG Has Limited Effects on Endocrine and Metabolic Parameters
por: Klipping, Christine, et al.
Publicado: (2021)

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
por: Angus, Lachlan, et al.
Publicado: (2019)

A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas
por: Lee, Keng Siang, et al.
Publicado: (2022)

Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

The Lifestyle Modifications and Endometrial Proteome Changes of Women With Polycystic Ovary Syndrome and Obesity
por: Abdulkhalikova, D., et al.
Publicado: (2022)

Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study
por: Stefanaki, Charikleia, et al.
Publicado: (2019)

Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia
por: Gemzell‐Danielsson, K, et al.
Publicado: (2021)

SUN-042 Low Dose Cyproterone Acetate for the Treatment of Transgender Women - a Retrospective Study
por: Even-Zohar, Naomi, et al.
Publicado: (2020)

Correction: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

Therapeutic effects of metformin and clomiphene in combination with lifestyle intervention on infertility in women with obese polycystic ovary syndrome
por: Zhang, Jing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mjv56hb5gfbe7himegjpibv0s5